摘要:
A process for producing a maturation bone morphogenetic protein by the action of a processing enzyme on a bone morphogenetic protein precursor, which comprises either introducing an expression vector of a bone morphogenetic protein precursor and an expression vector of a processing enzyme into an aminol cell strain, culturing the resultant strain to yield a maturation bone morphogenetic protein, and separating the same from the culture, or alternatively adding a solution of a processing enzyme to a solution of a bone morphogenetic protein precursor and incubating the obtained solution mixture. A suitable process comprises introducing an expression vector of a human MP52 precursor and an expression vector of a secretory furin variant into an established animal cell strain, culturing the resultant strain to yield a maturation bone morphogenetic protein, and separating the same from the culture.
摘要:
A model transgenic non-human vertebrate for interleukin-1 relevant diseases obtained by integrating into a vertebrate gene a foreign gene construction which contains a DNA sequence encoding an interleukin-1α gene in the downstream of the DNA sequence of a cytomegalovirus enhancer and the DNA sequence of chicken β-actin promoter.
摘要:
A cartilage and bone morphogenetic repairing material which contains a bone morphogenetic protein and a polyoxyethylene-p-olyoxypropylene glycol. In particular, it is preferable that a molecular weight of a polypropylene glycol, i.e., a component of said polyoxyethylene-polyoxypropylene glycol, being in the range of about 1,500-4,000 and a weight ratio of ethylene oxide being in the range of 40-80%/molecule, and a concentration of said polyoxyethylene-polyoxypropylene glycol in an aqueous solution being about 10-50%. It may be applied in a cartilage and bone morphogenetic method requiring no surgical operation and which comprises a bone morphogenetic protein and a carrier having a high bio-absorption, a good affinity to the bone morphogenetic protein and capable of temperature dependent gel-sol reversible transition. It is convenient to apply locally to the site of bone fracture or bone defect with efficient treatment effect.
摘要:
The present invention provides proteins named HMW human MP52s having some amino acid sequence of SEQ ID NO.:1 which are produced in CHO cells. The present invention also provides a process for the production of HMW human MP52s and a pharmaceutical composition containing as an active ingredient HMW human MP52s. HMW human MP52s can be used for treating or preventing bone diseases, etc . due to their property of promoting bone morphogenesis.
摘要翻译:本发明提供了在CHO细胞中产生的具有SEQ ID NO:1的氨基酸序列的HMW人MP52的蛋白质。 本发明还提供了生产HMW人MP52的方法和含有HMW人类MP52的活性成分的药物组合物。 HMW人MP52可以用于治疗或预防骨骼疾病等,因为它们促进骨形态发生的性质。